[F-18]-fluorodeoxyglucose PET-CT of the normal prostate gland

被引:27
|
作者
Jadvar, Hossein [1 ]
Ye, Wei [1 ]
Groshen, Susan [1 ]
Conti, Peter S. [1 ]
机构
[1] Univ So Calif, Dept Radiol & Biomed Engn, PET Imaging Sci Ctr, Los Angeles, CA 90033 USA
关键词
Prostate; FDG; PET-CT;
D O I
10.1007/s12149-008-0177-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective We determined the glucose metabolism and computed tomographic (CT) density of the normal prostate gland in relation to age and prostate size on [ F-18]fluorodeoxyglucose positron emission tomography (PET)-CT. Methods We determined the CT density (Hounsfield Units, HU) and glucose metabolism (standardized uptake value, SUV) of the normal prostate in 145 men (age range 22-97 years) on PET-CT scans which were performed for indications unrelated to prostate pathology. Correlations among SUV, HU, prostate size, and age were calculated using Pearson's correlation coefficients, scatter plots, and linear regression trend lines. The SUV and HU values were also compared among different primary cancer types using the Kruskal-Wallis test. Results The population average and range of the normal prostate size were 4.3 +/- 0.5 cm (mean +/- SD) and 2.9-5.5 cm, respectively. The population average of mean and maximum CT densities was 36.0 +/- 5.1 HU (range 23-57) and 91.7 +/- 20.1 HU (range 62-211), respectively. The population average of mean and maximum SUV was 1.3 +/- 0.4 (range 0.1-2.7) and 1.6 +/- 0.4 (range 1.1-3.7), respectively. Mean SUV tended to decrease as the prostate size increased (r = -0.16, P = 0.058). Higher mean HU was correlated with higher mean SUV (r = 0.18, P = 0.033). The strongest association was observed between age and prostate size. The prostate gets larger as age increases (r = 0.32, P < 0.001). Prostate mean SUV, max SUV, mean HU, and max HU were not significantly different among different types of primary cancers. Conclusions Although the normal prostate size increases with age, it does not significantly affect the gland's metabolism and CT density, and therefore age correction of these parameters may be unnecessary.
引用
收藏
页码:787 / 793
页数:7
相关论文
共 50 条
  • [1] [F-18]-fluorodeoxyglucose PET-CT of the normal prostate gland
    Hossein Jadvar
    Wei Ye
    Susan Groshen
    Peter S. Conti
    Annals of Nuclear Medicine, 2008, 22 : 787 - 793
  • [2] Dermatofibroma mimicking malignancy on integrated F-18 fluorodeoxyglucose PET-CT
    Demir, Mustafa Kemal
    Ozdemir, Huseyin
    Genchallac, Hakan
    Altaner, Semsi
    Kartal, Oezcan
    DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2009, 15 (01) : 61 - 63
  • [3] Mediastinoscopy and F-18 PET-CT in NSCLC
    Sivrikoz, M. C.
    Ak, I.
    Dundar, E.
    Simsek, F. S.
    Tulay, C. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S318 - S318
  • [4] Imaging Lymphoma With F-18 Fluorodeoxyglucose PET-CT: What Should Be Known About Normal Variants, Pitfalls, and Artifacts?
    Vangu, Mboyo Di Tamba
    Momodu, Jaleelat I.
    FRONTIERS IN NUCLEAR MEDICINE, 2022, 1
  • [5] F-18 FDG PET/PET-CT in the management of lymphoma
    Dhanapathi, Halanaik
    Kumar, Rakesh
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2007, 28 (03) : 17 - 23
  • [6] Is F-18 Fluorodeoxyglucose PET/CT Useful In The Management Of TENIS?
    Bhattacharya, A.
    Singh, D.
    Jois, A.
    Sood, A.
    Mittal, B. R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S787 - S787
  • [7] Characterization of F-18 fluorodeoxyglucose PET/CT in granulomatosis with polyangiitis
    Nelson, D.
    Johnson, G.
    Cartin-Ceba, R.
    Specks, U.
    PRESSE MEDICALE, 2013, 42 (04): : 710 - 710
  • [8] CHARACTERIZATION OF F-18 FLUORODEOXYGLUCOSE PET/CT IN GRANULOMATOSIS WITH POLYANGIITIS
    Nelson, Darlene R.
    Johnson, Geoffrey B.
    Cartin-Ceba, Rodrigo
    Specks, Ulrich
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2015, 32 (04) : 342 - 352
  • [9] F-18 Fluorodeoxyglucose PET/CT Findings in Active Hiccups
    Yeatman, C. Fitzhugh, II
    Minoshima, Satoshi
    CLINICAL NUCLEAR MEDICINE, 2009, 34 (03) : 197 - 198
  • [10] F-18 Fluciclovine PET-CT Findings and Pseudoprogression on Immunotherapy
    Poindexter, Bradley C.
    Kasireddy, Nandita M.
    Molchanova-Cook, Olga P.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (10)